Therefore, we applied the specific STAT3/5 inhibitors Stattic and SH-4-54 to 10 different bladder cancer cell lines, and Nifuroxazide in T24 and RT112 cell lines. This evidence concerns the gene STAT3 and urinary bladder carcinoma.